documents: FDA-2017-D-5928-0007

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2017-D-5928-0007 FDA FDA-2017-D-5928 Post-Complete Response Letter Meetings Between the Food and Drug Administration and Abbreviated New Drug Application Applicants Under Generic Drug User Fee Amendments; Guidance for Industry; Availability Notice Notice of Availability 2018-12-04T05:00:00Z 2018 12 2018-12-04T05:00:00Z   2022-10-05T19:15:10Z 2018-26285 0 0 0900006483939624

Links from other tables